JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB227381

Anti-STK17A 抗体

Anti-STK17A antibody

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Polyclonal STK17A antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human STK17A.

別名を表示する

DRAK1, STK17A, Serine/threonine-protein kinase 17A, DAP kinase-related apoptosis-inducing protein kinase 1

1 Images
Western blot - Anti-STK17A antibody (AB227381)
  • WB

Supplier Data

Western blot - Anti-STK17A antibody (AB227381)

10% SDS PAGE

All lanes:

Western blot - Anti-STK17A antibody (ab227381) at 1/1000 dilution

All lanes:

HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 30 µg

Predicted band size: 47 kDa

true

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

WB

applications

免疫原

Recombinant Fragment Protein within Human STK17A. The exact immunogen used to generate this antibody is proprietary information.

Q9UEE5

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/3000", "WB-species-notes": "<p></p>" } } }
style
left-column
style
left-column

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
pH: 7 Preservative: 0.01% Thimerosal (merthiolate) Constituents: 10% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle
style
left-column

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

STK17A also known as DRAK1 is a serine/threonine-protein kinase with a mass of approximately 45 kDa. This protein performs a role in cellular signal transduction by phosphorylating serine and threonine residues on target substrates. STK17A is expressed in a variety of human tissues with significant expression in the brain heart and skeletal muscle indicating its widespread regulatory functions.
Biological function summary

The kinase activity of STK17A affects processes like apoptosis and cell migration. It does not form a complex with other proteins but can directly interact with them to exert its influence. Through these interactions STK17A can regulate cell survival and death which are important in development and homeostasis within an organism.

Pathways

STK17A acts in the apoptosis signaling pathway and is known to modulate JNK (c-Jun N-terminal kinase) signaling. In the apoptosis pathway STK17A can modify the response of cells to stress stimuli effectively controlling programmed cell death. It shows functional association with proteins such as caspases which carry out the execution phase of apoptosis thereby linking STK17A to these essential cellular processes.

Dysregulation of STK17A has connections to cancer and neurodegenerative disorders. In cancer altered STK17A expression or activity can contribute to inappropriate cell survival and proliferation making it a relevant marker or target in tumor biology. It associates with proteins like Bcl-2 which are involved in promoting cell survival. In neurodegenerative disorders such as Alzheimer's disease changes in STK17A expression or function might affect neuronal apoptosis contributing to the pathology of these conditions.
style
left-column
style
left-column

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

ターゲットの情報

Acts as a positive regulator of apoptosis. Also acts as a regulator of cellular reactive oxygen species.
See full target information STK17A
style
left-column

文献 (1)

Recent publications for all applications. Explore the full list and refine your search

BMC biology 23:214 PubMed40660178

2025

Organic cation transporter 3 on neuronal mitochondria mediates MPP-induced mitochondrial dysfunction and neurotoxicity in a TIMM22-dependent manner.

Applications

Unspecified application

Species

Unspecified reactive species

Ao Guan,Sida Han,Suzhen Liang,Weiwei Shen,Min Guo,Mei Cui
View all publications
style
left-column
style
left-column
style
right-column

代替製品

Primary Antibodies

AB97530

Anti-STK17A antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-STK17A antibody (AB97530)

  • 0
  • 0
Primary Antibodies

AB8418

Anti-STK17A antibody

Immunocytochemistry - Anti-STK17A antibody (AB8418)

  • 0
  • 0

組合せ製品

Primary Antibodies

AB255865

Anti-Ataxin 3 antibody [EPR22418-147] - BSA and Azide free

RabMAb|Recombinant

Indirect ELISA - Anti-Ataxin 3 antibody [EPR22418-147] - BSA and Azide free (AB255865)

  • 0
  • 0
Secondary Antibodies

AB150077

Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488)

Immunocytochemistry/ Immunofluorescence - Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (AB150077)

  • 5
  • 20
Primary Antibodies

AB32072

Anti-c-Myc antibody [Y69] - ChIP Grade

BOND RX™ Validated|KO Validated|RabMAb|Recombinant|Lab Essentials|20ul selling size|Advanced Validation

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-c-Myc antibody [Y69] - ChIP Grade (AB32072)

  • 4
  • 56
Primary Antibodies

AB46154

Anti-VEGFA antibody

Lab Essentials

Western blot - Anti-VEGFA antibody (AB46154)

  • 5
  • 29

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com